Profil
Mr. Philippe Ledent is a Chief Scientific Officer & Director at Xpress Biologics SA and a Senior Economist at ING Belgium SA/NV.
He is on the Board of Directors at Xpress Biologics SA. He’s responsible for economic scenario and structural research on Belgium and Luxembourg.
Previously, he worked at the Catholic University of Louvain.
Aktive Positionen von Philippe Ledent
| Unternehmen | Position | Beginn |
|---|---|---|
ING Belgium SA/NV
 ING Belgium SA/NV Investment Banks/BrokersFinance ING Belgium SA/NV is the wholly owned securities broker/dealer subsidiary of ING Groep NV (AMS: INGA) in The Netherlands. Headquartered in Brussels, the firm provides brokerage services to various investors. | Ökonom | 01.01.2008 |
Xpress Biologics SA
 Xpress Biologics SA BiotechnologyHealth Technology Xpress Biologics SA develops and produces bio molecules for medical applications. It engages in design of expression systems, process development and manufacturing of new biologics, biosimilars and biobetters, management of the pre-clinical and clinical trials and management of the GMP manufacturing services. The company was founded by Marc Daukandt, Philippe Ledent and Christian Rodriguez on April 14, 2014 and is headquartered in Milmort, Belgium. | Gründer | 14.04.2014 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
ING Belgium SA/NV
ING Belgium SA/NV Investment Banks/BrokersFinance ING Belgium SA/NV is the wholly owned securities broker/dealer subsidiary of ING Groep NV (AMS: INGA) in The Netherlands. Headquartered in Brussels, the firm provides brokerage services to various investors. | Finance |
Xpress Biologics SA
Xpress Biologics SA BiotechnologyHealth Technology Xpress Biologics SA develops and produces bio molecules for medical applications. It engages in design of expression systems, process development and manufacturing of new biologics, biosimilars and biobetters, management of the pre-clinical and clinical trials and management of the GMP manufacturing services. The company was founded by Marc Daukandt, Philippe Ledent and Christian Rodriguez on April 14, 2014 and is headquartered in Milmort, Belgium. | Health Technology |
